Your search returned 6 results.

Results
	1.	Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors: Aroda, Vanita R PMID: 27284114 Year: 2016 Citation: Diabetes Care. 39(9):1579-86, 2016 Sep Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T DOI: https://dx.doi.org/10.2337/dc16-0046 Add to cart (remove)
	2.	The role of chronic and perioperative glucose management in high-risk surgical closures: a case for tighter glycemic control. MedStar authors: Masden, Derek PMID: 23783058 Year: 2013 Citation: Plastic & Reconstructive Surgery. 132(4):996-1004, 2013 Oct. Institution: Curtis National Hand Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Attinger C, Endara M, Goldstein J, Gondek S, Masden D, Steinberg J DOI: http://dx.doi.org/10.1097/PRS.0b013e31829fe119 Add to cart (remove)
	3.	Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors: Ratner, Robert E PMID: 24650952 Year: 2014 Citation: Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T DOI: http://dx.doi.org/10.1016/j.jdiacomp.2014.01.012 Add to cart (remove)
	4.	Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors: Aroda, Vanita R PMID: 27650977 Year: 2016 Citation: Diabetes Care. 39(11):1972-1980, 2016 Nov Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C DOI: https://dx.doi.org/10.2337/dc16-1495 Add to cart (remove)
	5.	Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors: Weissman, Neil J PMID: 22421927 Year: 2012 Citation: Obesity. 20(7):1426-36, 2012 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J DOI: http://dx.doi.org/10.1038/oby.2012.66 Add to cart (remove)
	6.	Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors: Ratner, Robert E PMID: 23175674 Year: 2013 Citation: Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb. Institution: MedStar Health Research Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Form of publication: Journal Article All authors: Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D DOI: http://dx.doi.org/10.1161/ATVBAHA.112.300346 Add to cart (remove)

Powered by Koha